MedCity News

Novel Parkinson’s Disease Drug Will Join AbbVie With Positive Phase 3 Data In Hand

Cerevel Therapeutics drug tavapadon met the main and secondary goals of a pivotal Parkinson’s disease clinical trial. That drug and others will join the neuroscience portfolio of AbbVie, which is in the process of acquiring Cerevel.

Cerevel Therapeutics drug tavapadon met the main and secondary goals of a pivotal Parkinson’s disease clinical trial. That drug and others will join the neuroscience portfolio of AbbVie, which is in the process of acquiring Cerevel.

The post Novel Parkinson’s Disease Drug Will Join AbbVie With Positive Phase 3 Data In Hand appeared first on MedCity News.

1 year 3 months ago

BioPharma, Daily, Pharma, AbbVie, biopharma nl, Cerevel Therapeutics, Clinical Trials, Parkinson's Disease, tavapadon

PAHO/WHO | Pan American Health Organization

Despite vaccination gains, 1.2 million children under one remain unprotected in the Americas

Despite vaccination gains, 1.2 million children under one remain unprotected in the Americas

Oscar Reyes

18 Apr 2024

Despite vaccination gains, 1.2 million children under one remain unprotected in the Americas

Oscar Reyes

18 Apr 2024

1 year 3 months ago

STAT

STAT+: Pharmalittle: We’re reading about BIO’s China challenge, Zepbound shortages, and more

Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny, nonetheless. Why?

We recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us. Our choice today is pistachio creme. Remember, a prescription is not required. So no need to mess with rebates. Meanwhile, here are a few items of interest. Hope you have a meaningful and productive day and, of course, do stay in touch. …

A photo shows the WuXi Biologics chief executive officer shaking hands with John Crowley, the incoming head of the Biotechnology Innovation Organization, but three months later, a sister company, WuXi AppTec and BIO, ended their relationship and Crowley openly supported legislation to ban many U.S. biotechs from doing business with the Chinese behemoth, STAT says. The about-face illustrates the difficulty the biotech industry faces in dealing with an issue that, fueled by national security concerns, is moving fast and forcefully. It also tests the ability of Crowley, who lacks a background in politics, to navigate a domestic policy issue that is tangled up in U.S.-China relations.

Cerevel Therapeutics, a neuroscience biotech that AbbVie is acquiring, reported that its Parkinson’s disease drug improved motor symptom control as an add-on therapy in a late-stage trial, STAT writes. When AbbVie announced its $8.7 billion acquisition of Cerevel last year, it emphasized a different drug in the biotech’s pipeline, emraclidine, which is being tested for schizophrenia and has potential in dementia-related psychosis in Alzheimer’s disease and Parkinson’s. While tavapadon doesn’t appear to be the key drug AbbVie focused on its acquisition, the new positive results still represent a win for the pharma company as it completes the deal.

Continue to STAT+ to read the full story…

1 year 3 months ago

Pharma, Pharmalot, pharmalittle, STAT+

Health Archives - Barbados Today

Minister encourages staff, public to use new gym at Psychiatric Hospital

Staff at the Psychiatric Hospital and the Ministry of Health and Wellness now have a dedicated space where they can prioritise their health and fitness, with the reopening of the Mind & Body Gym at the Black Rock, St Michael institution.

Minister of State in the Ministry of Health and Wellness, Davidson Ishmael, officially opened the facility on Wednesday, stating that it was also open to members of the public for a nominal fee.

“I want that as soon as we cut this ribbon that people can actually start utilising the space. It may not be a Surfside gym, but it is still a premium facility and of very high quality in terms of equipment, infrastructure and space.

“As we have invested . . . in you [the staff] and your wellbeing, I want to encourage every member of the Psychiatric Hospital team and those at the rest of the healthcare facilities, in addition to the public of Barbados to make good use of this space,” Ishmael said.

The minister added that if “we are going to be talking about health and wellness as a Ministry of Health and Wellness, we have to make sure that we’re providing as many avenues and opportunities for our staff or team members to be at their optimum”.

“Part of being at your optimum is being able to have access to healthcare facilities and also gym facilities that would allow you to be able to function at your best. We believe that everyone has a right to good healthcare, mental health as you guys are part of this whole mental health system and infrastructure that we have placed in Barbados to be able to provide this service to our people. We understand that you, too, have to be at your best level and at your best quality of mental healthcare . . . ,” he said.

Ishmael explained that the reopening of the facility was another prong in government’s efforts to ensure that the island’s healthcare service providers are given access to spaces that would allow them to be at their best.

“Therefore, you can then provide that service, that excellent service that you’re already doing [and] continue to provide that excellent service to the patients who are here at the hospital as well.”

He urged members of the public to utilise the facilities which will be made accessible to them at a “minimal” fee.

“We want persons to be able to come into the actual environment of the Psychiatric Hospital, understanding that this is a safe space. It is a safe space, just like any other space in Barbados, and we therefore want people to be able to traverse through understanding that they can come to this gym.

“They can exercise within the environs of persons who are seeking assistance and seeking care, but this is not a place that they can run from or should run from, but this is a place where we can embrace holistically as a society,” Ishmael said. (BGIS/FW)

 

The post Minister encourages staff, public to use new gym at Psychiatric Hospital appeared first on Barbados Today.

1 year 3 months ago

Health, Local News

STAT

STAT+: Cerevel drug for Parkinson’s disease improved symptom control in trial

Cerevel Therapeutics, a neuroscience biotech that AbbVie is acquiring, reported that its drug for Parkinson’s disease improved motor symptom control as an add-on therapy in a late-stage trial.

Cerevel Therapeutics, a neuroscience biotech that AbbVie is acquiring, reported that its drug for Parkinson’s disease improved motor symptom control as an add-on therapy in a late-stage trial.

The 27-week study found that patients taking the drug, tavapadon, on top of a common Parkinson’s treatment called levodopa, experienced 1.7 hours of improvement in “on time” without dyskinesia, which is the amount of time patients function well without involuntary movements that can be brought on by levodopa. That compared to 0.6 hours of improvement among patients taking placebo and levodopa.

This difference was statistically significant and clinically meaningful, Cerevel said in a press release Thursday. There was also a statistically significant decrease in “off time,” the amount of time patients experienced symptoms. The full results will be submitted for presentation at future medical meetings.

Continue to STAT+ to read the full story…

1 year 3 months ago

Biotech, AbbVie, biotechnology, neuroscience, STAT+

STAT

STAT+: Pharmalittle: We’re reading about Lilly’s Zepbound for sleep apnea, the FDA budget, and more

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation.

Our choice today is maple bourbon. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch…

Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market, STAT tells us. The results also pave the way for Zepbound to potentially become the first approved treatment for obstructive sleep apnea, or OSA, a common disorder characterized by breathing interruptions during sleep. Obesity is a major risk factor of OSA, which is estimated to affect approximately 39 million U.S. adults, though many cases are undiagnosed, according to the National Council on Aging. Getting approval for indications other than weight loss would help Lilly in its attempts to expand insurance coverage.

Sage Therapeutics will stop development of its experimental drug to treat Parkinson’s disease after the treatment failed a mid-stage study, sending the company’s shares tumbling 36% before stock trading opened, Reuters reports. Parkinson’s disease, a progressive movement disorder of the nervous system, affects about 1 million people in the U.S. The failure is the latest hurdle for Sage Therapeutics after the U.S. health regulator last year approved the company’s and partner Biogen’s pill Zurzuvae as a treatment for postpartum depression, but rejected it for clinical depression, which is a much larger market.

Continue to STAT+ to read the full story…

1 year 3 months ago

Pharma, Pharmalot, pharmalittle, STAT+

Health Archives - Barbados Today

Increased wait times at some polyclinic pharmacies

The Barbados Drug Service (BDS) has advised that persons should expect

increased wait times at some polyclinic pharmacies, until further notice, due to the implementation of a new Pharmacy Management System.

These include the pharmacies at the Winston Scott Polyclinic, David

The Barbados Drug Service (BDS) has advised that persons should expect

increased wait times at some polyclinic pharmacies, until further notice, due to the implementation of a new Pharmacy Management System.

These include the pharmacies at the Winston Scott Polyclinic, David

Thompson Health and Social Services Complex, St Joseph Out-Patients Clinic, and the St Andrew Out-Patients Clinic.

The new system is expected to result in an improvement in patient records

management, treatment, and pharmaceutical health care and safety.

Management of the BDS regrets any inconvenience this temporary increase in wait times may cause and encourages members of the public to arrange their business accordingly. (BGIS)

The post Increased wait times at some polyclinic pharmacies appeared first on Barbados Today.

1 year 3 months ago

Health, Local News

Medical Daily

19 Botched Botox Cases Reported Across 9 States: CDC, FDA Investigate

Officials said that all the incidents involved women who reported sick following the administration of counterfeit Botox injections of AbbVie or those who received injections from unlicensed or untrained individuals in non-healthcare environments.

Officials said that all the incidents involved women who reported sick following the administration of counterfeit Botox injections of AbbVie or those who received injections from unlicensed or untrained individuals in non-healthcare environments.

1 year 3 months ago

Health

Identifying alternative cancer treatment methods

Cancer is a health problem responsible for one in six deaths worldwide. In 2020, there was an estimated 19.3 million new cancer cases, and about 10 million cancer deaths globally. Cancer is a very complicated sequence of events, progressing...

Cancer is a health problem responsible for one in six deaths worldwide. In 2020, there was an estimated 19.3 million new cancer cases, and about 10 million cancer deaths globally. Cancer is a very complicated sequence of events, progressing...

1 year 3 months ago

Health

Medicinal properties of the breadfruit

Breadfruit ( Artocarpus altilis) is the fruit of the breadfruit tree, though it is often referred to as a vegetable when consumed before it is fully ripe. It comes from the same family as jackfruit and mulberry. Similar to bananas and plantains,...

Breadfruit ( Artocarpus altilis) is the fruit of the breadfruit tree, though it is often referred to as a vegetable when consumed before it is fully ripe. It comes from the same family as jackfruit and mulberry. Similar to bananas and plantains,...

1 year 3 months ago

Healio News

VIDEO: Cedars-Sinai efforts aim to reduce disparities in Black maternal health

Risk for maternal mortality for Black women in the U.S. is double that of white women.

Barriers to improving maternal health outcomes for Black women stem from years of structural racism and bias, according to Kimberly Gregory, MD, MPH.Gregory is director of maternal-fetal medicine and vice chair of women’s health care quality and performance improvement in the department of obstetrics and gynecology at Cedars-Sinai.“Some of the obvious barriers are access either by way of insurance , lack of insurance, social determinants of life resulting in either difficulty or further distance

1 year 3 months ago

STAT

STAT+: Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus, where the official mascots are snoozing cozily in their respective corners and the usual din of motor cars is nowhere to be heard. So this calls for a celebratory cup of stimulation. Our choice today is the oh-so tasty hazelnut mocha.

Please feel free to join us. Meanwhile, here are a few items of interest to start you on your journey, which we hope is productive and meaningful. Have a grand day, and do keep in touch. …

The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment, one of the best-selling medicines in the U.S., surged to 36% from just 5% during the first week of April, thanks to the expanding reach that CVS Health has over the prescription drug market, STAT writes. The big jump was attributed to one particular biosimilar called Hyrimoz, which is manufactured by Sandoz, a former unit of Novartis that is a leading supplier of generic and biosimilar medicines. However, Hyrimoz is jointly marketed with Cordavis, a new subsidiary that CVS created last August specifically to sell biosimilar medicines in the U.S.

Shah Capital is seeking a change in leadership at Novavax and wants to appoint two handpicked directors, Pharmaphorum notes. In an open letter, the hedge fund accuses Novavax’s leadership of squandering its “many significant competitive advantages and sizeable market opportunity” due to “self-inflicted problems” under the current team led by chief executive John Jacobs. The bid by Shah Capital – which owns 6.7% of Novavax and is one of its top five shareholders – comes as the company has seen its share price come under massive pressure since the midst of the Covid-19 pandemic, when its shares were trading above $290 and it had a valuation of more than $40 billion.

Continue to STAT+ to read the full story…

1 year 3 months ago

Pharma, Pharmalot, pharmalittle, STAT+

PAHO/WHO | Pan American Health Organization

PAHO shares innovative country experiences to promote vaccination in the Americas

PAHO shares innovative country experiences to promote vaccination in the Americas

Cristina Mitchell

16 Apr 2024

PAHO shares innovative country experiences to promote vaccination in the Americas

Cristina Mitchell

16 Apr 2024

1 year 3 months ago

KFF Health News

California Health Workers May Face Rude Awakening With $25 Minimum Wage Law

SACRAMENTO, Calif.

— Nearly a half-million health workers who stand to benefit from California’s nation-leading $25 minimum wage law could be in for a rude awakening if hospitals and other health care providers follow through on potential cuts to hours and benefits.

A medical industry challenge to a new minimum wage ordinance in one Southern California city suggests layoffs and reductions in hours and benefits, including cuts to premium pay and vacation time, could be one result of a state law set to begin phasing in in June. However, some experts are skeptical of that possibility.

The California Hospital Association brought a partly successful legal challenge to Inglewood’s $25 minimum wage ordinance, which barred employers from taking those sorts of steps to offset their higher costs.

“Layoffs, reductions in premium pay rates, reductions in non-wage benefits, reductions in hours, and increased charges are consequences of an employer having less money to spend—which will necessarily be the case given the significant increase in spending on wages due to the minimum wage,” the association said in its lawsuit. Additional examples include reducing health coverage and charging for parking or work-related equipment.

Inglewood voters approved the ordinance in November 2022, nearly a year before California legislators enacted a $25 minimum wage for health workers. Those statewide higher wages are to be phased in starting in June under California’s first-in-the-nation law, but Gov. Gavin Newsom has since said they are too expensive as the state faces a deficit estimated between $38 billion and $73 billion. It’s unclear if lawmakers will agree to a delay or take other steps to reduce the cost.

U.S. District Judge Dale S. Fischer agreed with the hospital industry in a March 11 tentative ruling when he shot down the portion of Inglewood’s ordinance banning layoffs and clawbacks by employers, while allowing the rest of the ordinance to remain in effect. He gave the sides time to object to his preliminary decision, though none did.

The California Hospital Association represents more than 400 hospitals and was a key backer of the state’s carefully crafted compromise law, which notably contains none of the employee safeguards included in the Inglewood ordinance.

Spokesperson Jan Emerson-Shea said the association doesn’t know how providers will react once the state law takes effect. “We don’t have any insights,” she said.

“The challenge for any health care organization is figuring out how to pay for the higher wages,” said Joanne Spetz, director of the Philip R. Lee Institute for Health Policy Studies at the University of California-San Francisco. “Since labor costs are the largest part of any health care organization’s costs, it’s hard to figure out how to reduce spending without looking at labor costs.”

Providers can try to increase revenues by bargaining for higher reimbursements from commercial insurers, she said. Public hospitals, nursing homes, and community clinics get most of their money through Medi-Cal, the state’s Medicaid program.

Providers could reduce the services they offer, pare back charity care, and cut or delay capital investments, Spetz said. In the long term, she expects some combination of spending cuts and revenue increases.

Both the state law and local ordinance cover far more than doctors and nurses, with a definition of health worker that includes janitors, housekeepers, groundskeepers, security guards, food service workers, laundry workers, and clerical staff.

The most recent estimate by the Health Care Program at the University of California-Berkeley Labor Center is that as many as 426,000 health workers would make an average of $6,400 extra in the law’s first year, a 19% average pay bump mainly benefiting lower-income workers of color and women. State finance officials project that well over 500,000 workers will benefit.

Researchers didn’t include layoffs and other potential staffing and benefit reductions when they projected the state law’s costs and benefits, said Laurel Lucia, the program’s director. But she pointed to initial projections by hospitals, doctors, and business and taxpayer groups that the wage hike would cost $8 billion annually, thereby imperiling services and resulting in higher premiums and higher costs for state and local governments.

“It seems like a contradiction to say this law’s going to cost billions of dollars while at the same time saying it’s going to reduce workers’ total compensation,” said Lucia, who projects a far lower price tag.

She added that state finance officials had anticipated that Medi-Cal reimbursements would reflect the increased labor costs, while Medicare would eventually at least partially compensate for the higher labor costs.

Michael Reich, chair of the Center on Wage and Employment Dynamics at UC Berkeley’s Institute for Research on Labor and Employment, and affiliated economist Justin Wiltshire recently argued that California’s new $20 minimum wage law for fast-food workers won’t result in mass layoffs and price increases, as some have predicted.

Health care is much different than fast food, Reich acknowledged, but he argued for much the same positive result.

“A higher minimum wage will make it easier and cheaper for hospitals to recruit and retain these workers. The cost savings, and the productivity benefits of more experienced workers, could offset much of the labor cost increase,” Reich said.

The hospital association filed its lawsuit against Inglewood’s ordinance in July, while it was still opposing early versions of the statewide minimum wage legislation. Among many other provisions, the statewide law put on hold an initiative to cap hospital executives’ salaries in Los Angeles.

The hospital association’s legal challenge referenced in part layoffs and reduced working hours imposed by Centinela Hospital Medical Center after Inglewood’s ordinance took effect.

But Centinela said the reduction was entirely unrelated to the ordinance and that all staff were offered alternate positions, which many accepted.

“Centinela Hospital also has since added many more jobs in new clinical positions above minimum wage scale,” the hospital said in a statement.

Service Employees International Union-United Healthcare Workers West, the prime backer of both the local ordinance and the statewide law, sued the hospital in April 2023 alleging that it cut workers’ hours to offset the higher minimum wage. The case is still pending.

The union did not respond to repeated requests for comment.

In a court filing, however, the union and city of Inglewood said similar employer restrictions in previous minimum wage laws have survived.

The ordinance “merely sets the backdrop for collective bargaining negotiations,” and does not bar employers from locking out employees or hiring replacement workers during a strike. Employers can still lay off workers or reduce their hours, they said, so long as they don’t do so to fund the higher minimum wage.

But Fischer agreed with the hospital association that layoffs and reductions in employees’ total compensation packages are “obvious responses by an employer to rising compensation costs.”

Restricting employers’ options would violate federal labor relations rules, he said.

“The minimum wage an employer has to pay its employees will invariably affect the total amount of compensation it is able or willing to pay,” he wrote “This will then invariably affect the number of employees it can retain and the number of hours those employees will be scheduled to work.”

This article was produced by KFF Health News, which publishes California Healthline, an editorially independent service of the California Health Care Foundation. 

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 4 months ago

california, Health Industry, States, Cost of Living, Hospitals, Legislation

STAT

STAT+: Thanks to CVS, a biosimilar version of AbbVie’s Humira is grabbing huge market share

The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment, one of the best-selling medicines in the U.S., surged to 36% from just 5% during the first week of April, thanks to the expanding reach that CVS Health has over the prescription drug market.

The big jump was attributed to one particular biosimilar called Hyrimoz, which is manufactured by Sandoz, a former unit of Novartis that is a leading supplier of generic and biosimilar medicines. However, Hyrimoz is jointly marketed with Cordavis, a new subsidiary that CVS created last August specifically to sell any number of biosimilar medicines in the U.S.

This connection is crucial to the sudden jump in Hyrimoz prescriptions. How so? On April 1, CVS Caremark, which is one of the largest pharmacy benefit managers in the U.S., removed Humira from its major national formularies for health plans that cover about 30 million lives. Then, Hyrimoz was added to the formularies, which are the lists of medicines that are covered by health insurance.

Continue to STAT+ to read the full story…

1 year 4 months ago

Pharma, Pharmalot, AbbVie, Biosimilars, drug pricing, STAT+

PAHO/WHO | Pan American Health Organization

PAHO presents key recommendations to increase equitable access to health at G20 event in Brazil

PAHO presents key recommendations to increase equitable access to health at G20 event in Brazil

Cristina Mitchell

15 Apr 2024

PAHO presents key recommendations to increase equitable access to health at G20 event in Brazil

Cristina Mitchell

15 Apr 2024

1 year 4 months ago

Health | NOW Grenada

Sources and benefits of natural sugars 

Natural honey, molasses, unrefined maple syrup, fruit purees, dates prunes and Stevia are examples of healthier alternatives which can be used in moderation in place of refined sugars

View the full post Sources and benefits of natural sugars  on NOW Grenada.

Natural honey, molasses, unrefined maple syrup, fruit purees, dates prunes and Stevia are examples of healthier alternatives which can be used in moderation in place of refined sugars

View the full post Sources and benefits of natural sugars  on NOW Grenada.

1 year 4 months ago

Health, PRESS RELEASE, cancer centre, centre for healthy eating and activity research, gfnc, sugar

KFF Health News

Rural Americans Are Way More Likely To Die Young. Why?

Three words are commonly repeated to describe rural America and its residents: older, sicker and poorer.

Obviously, there’s a lot more going on in the nation’s towns than that tired stereotype suggests. But a new report from the Agriculture Department’s Economic Research Service gives credence to the “sicker” part of the trope.

Three words are commonly repeated to describe rural America and its residents: older, sicker and poorer.

Obviously, there’s a lot more going on in the nation’s towns than that tired stereotype suggests. But a new report from the Agriculture Department’s Economic Research Service gives credence to the “sicker” part of the trope.

Rural Americans ages 25 to 54 — considered the prime working-age population — are dying of natural causes such as chronic diseases and cancer at wildly higher rates than their age-group peers in urban areas, according to the report.

The USDA researchers analyzed mortality data from the Centers for Disease Control and Prevention from two three-year periods — 1999 through 2001, and 2017 through 2019. In 1999, the natural-cause mortality rate for rural working-age adults was only 6 percent higherthan that of their city-dwelling peers. By 2019, the gap had widened to 43 percent.

The disparity was significantly worse for women — and for Native American women, in particular. The gap highlights how persistent difficulties accessing health care, and a dispassionate response from national leaders, can eat away at the fabric of rural communities.

A possible Medicaid link

USDA researchers and other experts noted that states in the South that have declined to expand Medicaid under the Affordable Care Act had some of the highest natural-cause mortality rates for rural areas. But the researchers didn’t pinpoint the causes of the overall disparity.

Seven of the 10 states that have not expanded Medicaid are in the South, though that could change soon because some lawmakers are rethinking their opposition, as KFF Health News previously reported.

The USDA’s findings were shocking but not surprising, said Alan Morgan, CEO of the National Rural Health Association. He and other health experts have maintained for years that rural America needs more attention and investment in its healthcare systems by national leaders and lawmakers.

Another recent report, from the health analytics and consulting firm Chartis, identified 418 rural hospitals that are “vulnerable to closure. Congress, trying to slow the collapse of rural health infrastructure, enacted the Rural Emergency Hospital designation, which became available last year.

That new classification aimed to keep some facilities from shuttering in smaller towns by allowing hospitals to discontinue many inpatient services. But it has so far attracted only about 21of the hundreds of hospitals that qualify.

It’s unlikely that things have improved for rural Americans since 2019, the last year in the periods the USDA researchers examined. The coronavirus pandemic was particularly devastating in rural parts of the country. 

Morgan wondered: How wide is the gap today? Congress, Morgan said, should direct the CDC to examine life expectancy in rural America before and after the pandemic: “Covid really changed the nature of public health in rural America.”

The National Rural Health Association’s current advocacy efforts include raising support on policies before Congress, including strengthening the rural health workforce and increasing funding for various initiatives focused on rural hospitals, sustaining obstetrics services, expanding physician training and addressing the opioid response, among others. 

This article is not available for syndication due to republishing restrictions. If you have questions about the availability of this or other content for republication, please contact NewsWeb@kff.org.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 4 months ago

Rural Health, The Health 202

Healio News

Trial to correlate food allergy prevention with lower health care costs

The Early Allergen System Experience trial will use real-world infant health care data to assess how the early introduction of allergens via supplements will impact the development of allergies and associated health care costs.“We are excited to help show that preventing food allergies can create significant savings for insurance companies, which should encourage them to invest in food allergy

prevention,” Daniel Zakowski, CEO and cofounder of Ready. Set. Food!, told Healio.Ready. Set. Food! is partnering with ObvioHealth to conduct the study with the goal of showing insurance

1 year 4 months ago

Pages